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Although a fraction of human blood memory CD4+
T cells expresses chemokine (C-X-C motif) receptor
5 (CXCR5), their relationship to T follicular helper
(Tfh) cells is not well established. Here we show
that human blood CXCR5+CD4+ T cells share func-
tional properties with Tfh cells and appear to repre-
sent their circulating memory compartment. Blood
CXCR5+CD4+ T cells comprised three subsets: T
helper 1 (Th1), Th2, and Th17 cells. Th2 and Th17
cells within CXCR5+, but not within CXCR5, com-
partment efficiently induced naive B cells to pro-
duce immunoglobulins via interleukin-21 (IL-21). In
contrast, Th1 cells from both CXCR5+ and CXCR5
compartments lacked the capacity to help B cells.
Patients with juvenile dermatomyositis, a systemic
autoimmune disease, displayed a profound skewing
of blood CXCR5+ Th cell subsets toward Th2 and
Th17 cells. Importantly, the skewing of subsets
correlated with disease activity and frequency of
blood plasmablasts. Collectively, our study suggests
that an altered balance of Tfh cell subsets contrib-
utes to human autoimmunity.
INTRODUCTION
Antibody responses are largely dependent on the help provided
by CD4+ T cells. CD4+ T cells are fundamental for the generation
of germinal centers (GCs), a discrete structure in secondary
lymphoid organs where selection of high-affinity B cells and
development of B cell memory occur (Allen et al., 2007;
MacLennan, 1994). Recently, CD4+ T cells present in B cell folli-
cles, named T follicular helper (Tfh) cells, have been established
as a T helper (Th) cell subset specialized for providing help to
B cells in GCs (Fazilleau et al., 2009; King et al., 2008). Tfh
cells express the chemokine (C-X-C motif) receptor 5 (CXCR5)108 Immunity 34, 108–121, January 28, 2011 ª2011 Elsevier Inc.(Breitfeld et al., 2000; Kim et al., 2001; Schaerli et al., 2000),
which allows their migration into B cell follicles in response to
the specific ligand CXCL13. Tfh cells secrete IL-4, IL-10, and
IL-21, cytokines that promote growth, differentiation, and class
switching of B cells (Ettinger et al., 2005; Good et al., 2006;
Pene et al., 2004). Tfh cells also express surface molecules
essential for helper functions, including CD40-ligand (CD40L)
and inducible costimulator (ICOS) (King et al., 2008). Tfh cells
express large amounts of B cell lymphoma 6 (Bcl-6) (Chtanova
et al., 2004; Rasheed et al., 2006), which is necessary and suffi-
cient for the development of Tfh cells in vivo (Johnston et al.,
2009; Nurieva et al., 2009; Yu et al., 2009). In contrast, B lympho-
cyte-induced maturation protein 1 (Blimp-1), a transcription
repressor that regulates the function of Bcl-6, inhibits the gener-
ation of Tfh cells (Johnston et al., 2009). Thus, Tfh cell generation
is controlled by the balance of these two transcription repres-
sors. This supports the hypothesis that the developmental
pathway of Tfh cells is distinct from that of other canonical Th
cell subsets (Nurieva et al., 2008). Alternatively, there is evidence
that mouse Tfh cells are heterogeneous and encompass distinct
subsets secreting cytokines characteristic of Th1, Th2, and Th17
cells (Bauquet et al., 2009; Fazilleau et al., 2009; King andMohrs,
2009; Reinhardt et al., 2009; Zaretsky et al., 2009). Furthermore,
mouse Th2 (Zaretsky et al., 2009) and Treg (Tsuji et al., 2009)
cells were shown to be convertible into Tfh cells in vivo. There-
fore, the relationship between Tfh cells and other Th cell subsets
still remains unclear. Notably, whereas all these studies were
performed with inbred mouse strains, whether Tfh cells in
humans are comprised of different subsets is largely unknown.
Previous studies have shown that tonsillar Tfh cells display
distinct phenotype and genetic profiles from other canonical
Th cell subsets (Chtanova et al., 2004; Kim et al., 2004; Rasheed
et al., 2006). However, as suggested in mouse studies, the
precursors of Tfh cells might be composed of heterogeneous
cell populations also in humans, and they might differentiate
into distinct types of Tfh cells.
Furthermore, although several mouse studies show that over-
representation of Tfh cells is associated with the development of
systemic autoimmunity (Linterman et al., 2009; Subramanian
et al., 2006; Vinuesa et al., 2005), their association with human
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autoimmune diseases such as lupus or rheumatoid arthritis
display high-affinity somatically mutated autoantibodies in sera
(Mietzner et al., 2008; Shlomchik et al., 1987), suggesting the
involvement of Tfh cells (or Tfh-committed extrafollicular cells
[Poholek et al., 2010]) in the pathogenesis. Although a systematic
approach would be required to define the role of Tfh cells in
human autoimmune diseases, obtaining lymph node samples
from patients routinely and/or longitudinally is extremely chal-
lenging. Therefore, there is a strong need to establish surrogate
strategies to assess the quality of Tfh cell responses in humans.
In this regard, analysis of blood CD4+ T cells expressing CXCR5
(Forster et al., 1994) might facilitate such studies. Several obser-
vations suggest a relationship betweenCXCR5+CD4+ T cells and
Tfh cells. For example, humans who show severely impaired GC
formation through deficiency of CD40-ligand or ICOS display
substantially fewer circulating CXCR5+CD4+ T cells (Bossaller
et al., 2006). On the contrary, CXCR5+CD4+ T cells expressing
ICOS are present at a higher frequency in blood of lupus patients
(Simpson et al., 2010). However, whether circulating CXCR5+
CD4+ T cells indeed share the phenotypic and functional proper-
ties of Tfh cells remains to be established.
Here we show that human blood CXCR5+CD4+ T cells appear
to represent a circulating pool of memory Tfh cells and can be
distinguished into Th1, Th2, and Th17 cell subsets with different
capacities to regulate B cell responses.We further show an alter-
ation of blood CXCR5+CD4+ T cell subsets in an autoimmune
disease, juvenile dermatomyositis (JDM).
RESULTS
Human Blood CXCR5+CD4+ T Cells Induce the
Differentiation of Naive B Cells toward Plasmablasts
In healthy adult blood, CXCR5 was expressed by 8.3% ± 1.8%
of CD4+ T cells and 18.9% ± 3.6% of memory (CD45RA)
CD4+ T cells (mean ± SD, n = 10) (Figure 1A). Consistent with
previous observations (Breitfeld et al., 2000; Kim et al., 2001;
Schaerli et al., 2000), blood CXCR5+CD4+ T cells expressed
CCR7 and CD62L, but few expressed activation molecules
expressed by Tfh cells, such as ICOS and CD69 (Figure S1A
available online), suggesting a resting state. Both CXCR5 and
CCR7 were functional, as shown by the fact that blood CXCR5+
CD4+ T cells migrated in response to the ligands CXCL13 and
CCL19, respectively (Figure S1B).
To determine their capacity to help B cells, memory
(CD45RA) CXCR5+ cells were sorted and cultured with autolo-
gous naive B (IgD+CD27CD19+) cells. Naive (CD45RA+) and
memory CXCR5CD4+ T cells were also sorted for comparison.
To mimic the antigen-specific interaction between T and B cells,
staphylococcal enterotoxin B (SEB), a superantigen, was added
to the cultures. Naive CD4+ T cells did not induce naive B
cells to produce immunoglobulins (Igs) (Figure 1B). Memory
CXCR5CD4+ T cells induced naive B cells to produce only
low amounts of IgM, but no IgG or IgA. In contrast, CXCR5+CD4+
T cells were potent at inducing naive B cells to produce IgM, IgG,
and IgA (Figure 1B). The Ig production was totally dependent on
cognate interactions between T and B cells, as shown by the fact
that naive B cells cocultured with CXCR5+CD4+ T cells did not
produce Igs in the absence of SEB (Figure 1C). CXCR5+CD4+T cells were also more efficient than CXCR5CD4+ T cells in
inducing memory B cells to produce Igs (Figure 1D).
Kinetics studies revealed that CXCR5+CD4+ T cells induced
naive B cells to produce IgG and IgA as early as day 6 of culture,
whereas CXCR5CD4+ T cells did not induce either IgG or IgA
secretion even at day 12 (Figure 1E). The number of viable
T cells was similar between the cultures of CXCR5 and CXCR5+
CD4+ T cells with naive B cells (Figures 1F, top, and Figure 1G),
indicating that the inability of CXCR5CD4+ T cells to induce
naive B cells to produce IgG or IgA was not due to their poor
survival. In contrast, the number of viable B cells was constantly
higher when naive B cells were cultured with CXCR5+ cells than
with CXCR5CD4+ T cells (Figure 1F, bottom). Of note, the
number of viable B cells decreased after day 5 even when
cultured with CXCR5+CD4+ T cells, suggesting that the T cells
could not fully support the survival of B cells in vitro. Nonetheless,
culturing naive B cells with CXCR5+CD4+ T cells yielded higher
numbers of CD38+CD19lo cells than with CXCR5CD4+ T cells
(Figures 1H and 1I), indicating that a fraction of surviving B
cells differentiated into plasmablasts. Consistently, CXCR5+
CD4+ T cells efficiently induced naive B cells to express activa-
tion-induced cytidine deaminase (AID, encoded byAICDA gene),
a factor required for class switching, and Blimp-1 (encoded
by PRDM1 gene), a transcription factor critical for the differentia-
tion of plasma cells, but not Bcl6 (encoded by BCL6 gene)
(Figure 1J).
Collectively, these observations show that blood CXCR5+
CD4+ T cells were more efficient than CXCR5CD4+ T cells at
inducing naive B cells to differentiate into plasmablasts and to
promote class switching.Blood CXCR5+CD4+ T Cells Help Naive B Cells
through IL-21
Similar to tonsillar Tfh cells, blood CXCR5+CD4+ T cells secreted
IL-21 upon contact with naive B cells, whereas CXCR5CD4+
T cells barely secreted IL-21 (Figure 2A). Although CXCR5+CD4+
T cells secreted IL-21 within 24 hr after interaction with naive B
cells, very low amounts, if any, of IL-21 was secreted by
CXCR5CD4+ T cells up to 96 hr (Figure S2A). Notably, CXCR5+
CD4+ T cells also secreted larger amounts of CXCL13 than
CXCR5CD4+ T cells (Figure 2B), a chemokine produced by
tonsillar Tfh cells (Kim et al., 2004; Rasheed et al., 2006).
Previous studies demonstrated that IL-21 secreted by tonsillar
Tfh cells plays a central role in the expansion and plasma cell
differentiation of cocultured B cells (Bryant et al., 2007). Similarly,
blocking IL-21 during the coculture of naive B cells with blood
CXCR5+CD4+ T cells resulted in a dose-dependent inhibition of
Ig secretion (Figure 2C) and B cell recovery (Figure 2D).
Conversely, addition of IL-21 resulted in the enhancement of
IgM secretion as well as the induction of IgG and IgA secretion
by naive B cells cultured with CXCR5, but not naive, CD4+
T cells (Figure 2E). Consistent with previous studies with Tfh cells
(Bauquet et al., 2009; Odegard et al., 2008; Vogelzang et al.,
2008), B cell help by blood CXCR5+CD4+ T cells was also depen-
dent on ICOS, as shown by the fact that blocking of ICOS-ICOS
ligand interaction inhibited both IL-21 secretion (Figure S2B) and
Ig secretion (Figure 2F). Large amounts of IL-10 was also
detected in the cocultures of CXCR5+CD4+ T cells and naiveImmunity 34, 108–121, January 28, 2011 ª2011 Elsevier Inc. 109
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Figure 1. Blood CXCR5+CD4+ T Cells Induce Naive B Cells to Differentiate into Ig-Producing Plasmablasts
(A) CXCR5 expression by blood CD4+ T cells. PBMCs were stained with CD3, CD4, CD45RA, and CXCR5 mAbs. Gated to CD3+CD4+ T cells.
(B) Blood naive, CXCR5, and CXCR5+CD4+ T cells were cultured with autologous naive B cells in the presence of SEB. Ig concentrations were measured at
day 12. One-way ANOVA test. Data from seven independent experiments. **p < 0.01, ***p < 0.001.
(C and D) CXCR5 or CXCR5+CD4+ T cells were cultured with naive (C) or memory (D) B cells in the presence of titrated doses of SEB. Ig concentrations at day 12
in (C) and day 6 in (D). n = 3, mean ± SD. Representative data from three independent experiments.
(E) Ig concentrations at different time points in the cultures of CXCR5 or CXCR5+CD4+ T cells with naive B cells. n = 3, mean ± SD. Representative data from four
independent experiments.
(F) Number of viable CD4+ T and B cells at different time points. Representative data from two independent experiments.
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CXCR5+ Th Cell Subsets and Their Alteration in JDMB cells (Figure 2G), and blocking IL-10 resulted in a partial inhibi-
tion of Ig secretion (Figure 2H).
Whether blood CXCR5+CD4+ T cells contain antigen-specific
memory cells has been controversial (Breitfeld et al., 2000;
Rivino et al., 2004; Schaerli et al., 2001). To address this issue,
isolated CXCR5 and CXCR5+CD4+ T cells were cocultured
with autologous monocytes that had been pulsed with inacti-
vated influenza (flu) virus, or cytomegalovirus, and the prolifera-
tion of T cells was analyzed at day 5. Whereas CXCR5CD4+
T cells proliferated robustly in response to the stimulation with
both viruses, these stimulations also induced CXCR5+CD4+
T cells to proliferate (Figure 2I) and to secrete cytokines,
including IL-2 and IFN-g (Figure 2J). Notably, CXCR5+CD4+
T cells secretedmore IL-2 than CXCR5CD4+ T cells in response
to the stimulation with virus antigens (Figure 2J). To directly illus-
trate the flu-specific CXCR5+CD4+ T cells, PBMCs obtained
from healthy donors (who did not receive influenza vaccines
more than 1 year) were incubated for 6 hr with either a seasonal
flu vaccine (Fluzone) or a heat-inactivated flu virus (PR8). Then
cells were analyzed for the expression of CD4 and CXCR5
together with the expression of intracytoplasmic CD154, which
permits the sensitive identification of antigen-specific CD4+
T cells (Chattopadhyay et al., 2006). Whereas CXCR5 is
expressed by activated CD4+ T cells (Schaerli et al., 2001),
CXCR5CD4+ T cells stimulated for 6 hr with SEB remained
negative for CXCR5 expression (Figure S2C). As shown in Fig-
ure 2K, flu-specific CD4+ T cells were detected as CD154+ cells
in both stimulations, which contained CXCR5+ cells. Further-
more, a fraction of flu antigen-specific (CD154+) CXCR5+CD4+
T cells also expressed intracytoplasmic IL-2 and/or IFN-g upon
stimulation (Figure S2D).
Collectively, these observations show that CXCR5+CD4+
T cells shared functional properties of Tfh cells. Inasmuch as
CXCR5+CD4+ T cells contained antigen-specific memory cells,
blood CXCR5+CD4+ T cells appear to represent circulating
memory Tfh cells.
Three Distinct Th Cell Subsets in Human Blood
The expression of chemokine receptors has been instrumental
for defining human CD4+ T cell subsets. The expression of
CXCR3 is preferentially maintained by cells committed to the
Th1 cell pathway (Bonecchi et al., 1998; Rabin et al., 2003;
Sallusto et al., 1998), whereas CCR6 is expressed by Th17 cells
(Acosta-Rodriguez et al., 2007; Annunziato et al., 2007; Singh
et al., 2008). Though blood CXCR5+CD4+ T cells were previously
shown to coexpress other chemokine receptors (Lim et al.,
2008), the relationship between chemokine receptor expression
and their function has not been established. As illustrated in
Figure 3A, differential expression of CXCR3 and CCR6 defined
three major subsets within blood CXCR5+CD4+ T cells: CXCR3+
CCR6, CXCR3CCR6, and CXCR3CCR6+ cells. CXCR5
CD4+ T cells contained four subpopulations including CXCR3+(G) Number of viable CD4+ T cells at day 8. Paired t test. Data from three indepe
(H) CD38+ plasmablast population in the coculture of blood Th cell subsets and na
(I) Number of plasmablasts in the cocultures. One-way ANOVA test. Data from th
(J) Measurement of BCL6, PRDM1, and AICDA mRNA expression by real-time R
mRNA was normalized to that of ACTB mRNA. Before and after 7 day culture wit
Representative data from two independent experiments.CCR6+ cells. When compared to CXCR5+CD4+ T cells, the
pool of CXCR5CD4+ T cells contained fewer CXCR3CCR6+
T cells (p < 0.01, paired t test) and more CXCR3+CCR6+ T cells
(p < 0.001) (Figure 3B).
To analyze the functional differences of blood memory CD4+
T cell populations, seven major subpopulations (four CXCR5
and three CXCR5+) were isolated according to the expression
of CXCR5, CXCR3, and CCR6. To analyze cytokine secretion
patterns, each subpopulation was cocultured for 2 days with
SEB-pulsed naive B cells. As expected (Figure 2A), all four
subpopulations within the CXCR5 compartment secreted
very little, if any, IL-21 upon interaction with naive B cells (Fig-
ure 3C). Within the CXCR5+CD4+ T cell compartment, only
CXCR3CCR6 and CXCR3CCR6+ cells produced IL-21.
Measurement of other cytokines revealed that each cell popula-
tion secreted different sets of cytokines (Figure 3D). CXCR3+
CCR6 cells in both CXCR5+ and in CXCR5 compartments
secreted IFN-g but not Th2 or Th17 cytokines. Th2 cytokines,
i.e., IL-4, IL-5, and IL-13, were exclusively secreted by CXCR3
CCR6 cells, whereas Th17 cytokines IL-17A and IL-22 were
produced byCXCR3CCR6+ cells, in bothCXCR5+ andCXCR5
cells. Expression profiling of transcription factors demonstrated
that within the CXCR5+CD4+ T cell compartment, CXCR3+
CCR6 cells expressed T-bet, a transcription factor of Th1 cells,
CXCR3CCR6 cells expressed GATA3, a transcription factor of
Th2 cells, whereas CXCR3CCR6+ cells expressed RORgT,
a transcription factor of Th17 cells (Figure 3E). The similar pattern
of transcription factor expression was also observed within
CXCR5CD4+ T cell compartment. Thus, both blood CXCR5+
and CXCR5CD4+ T cells included Th1, Th2, and Th17 cells.
Next we analyzed the expression of BCL6 and PRDM1 tran-
scripts in blood memory Th cell subsets with real-time RT-
PCR. Several reports demonstrated that blood CXCR5+CD4+
T cells express much lower amounts of BCL6 transcript than
tonsillar Tfh cells (Chtanova et al., 2004; Rasheed et al., 2006;
Simpson et al., 2010). Consistently, the expression ofBCL6 tran-
script was similar among CXCR5+ and CXCR5 Th cell subsets
(Figure 3F). However, PRDM1 transcript expression was lower in
all the CXCR5+ Th cell subsets than in their counterparts in
CXCR5 cells. Thus, the balance between Bcl-6 and Blimp-1
appears to be differentially regulated between CXCR5+ and
CXCR5 Th cell subsets.
CXCR5+ Th2 and CXCR5+ Th17 Cells Help B Cell
Differentiation
Wenext examined the ability of the seven blood CD4+ T cell pop-
ulations to help naive B cells. The sorted CD4+ T cells were
cultured with SEB-pulsed naive B cells for 12 days, and secreted
Ig concentrations were measured. Both CXCR5+ and CXCR5
Th1 (CXCR3+CCR6) cells failed to induce naive B cells to
produce Igs (Figures 4A and 4B). CXCR5+ Th1 cells were also
incapable of inducing memory B cells to produce Igsndent experiments.
ive B cells at day 8. Representative data from three independent experiments.
ree independent experiments.
T-PCR in naive B cells cultured with blood Th cell subsets. Expression of each
h CXCR5 or CXCR5+CD4+ T cell subsets (B cells were purified after culture).
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Figure 2. Blood CXCR5+CD4+ T Cells Depends on IL-21, IL-10, and ICOS for B Cell Help
(A) IL-21 secretion by blood Th cell subsets cultured with naive B cells. Data from six independent experiments. One-way ANOVA test. **p < 0.01.
(B) CXCL13 secretion by blood Th cell subsets cultured with naive B cells. n = 3. Mean ± SD. Representative data from three independent experiments.
(C) Titrated amounts of IL-21R-Fcwere added to the coculture of CXCR5+CD4+ T cells and naive B cells. Ig concentrations at day 12. IgG is not shown because of
the cross-reactivity to the Fc portion of IL-21R-Fc. Representative data from two independent experiments.
(D) Recovery of viable B cells at day 12. Normalized to the culture of CXCR5+CD4+ T cells and naive B cells. One-way ANOVA test, n = 4. ***p < 0.001.
(E) Titrated amounts of IL-21 were added to the coculture of naive or CXCR5CD4+ T cells with naive B cells. Ig concentrations at day 12. n = 3, mean ± SD.
Representative data from three independent experiments.
(F) Ig concentrations at day 12 in the coculture of CXCR5+CD4+ T cells and naive B cells with an ICOS-blocking reagent. n = 3; mean ± SD. Representative data
from two independent experiments.
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CXCR5+ Th Cell Subsets and Their Alteration in JDM(Figure S3A). Among Th2 (CXCR3CCR6) cells, CXCR5+ cells
induced naive B cells to produce IgM, IgG, IgA, and IgE. In
contrast, CXCR5 Th2 cells induced B cells to secrete only
IgM and small amounts of IgE, but virtually no IgG and IgA
(Figures 4A and 4B). Among Th17 (CXCR3CCR6+) cells,
CXCR5+ cells potently induced naive B cells to produce IgM,
IgG, and IgA, but not IgE. However, CXCR5 Th17 cells
completely lacked the capacity to help naive B cells (Figures
4A and 4B). The inability of CXCR5+ Th1 cells to help naive B cells
was not due to the poor survival of T cells in the cultures (Fig-
ure 4C), but due to the lack of capacity to maintain the survival
of B cells (Figure 4D). In contrast, CXCR5+ Th2 and Th17 cells
efficiently induced naive B cells to proliferate and to differentiate
into CD19loCD38+ plasmablasts (Figure 4D).
Whereas CXCR5+ Th2 cells and Th17 cells induced naive
B cells to produce comparable amounts of IgG (Figure 4B) and
its subclasses (Figure S3B), CXCR5+ Th17 cells induced naive
B cells to produce higher amounts of IgA (Figure 4B), in particular
IgA2 (Figure 4E), than did CXCR5+ Th2 cells. Blocking IL-21 in the
culture of naive B cells with CXCR5+ Th2 cells resulted in
a substantial decrease in IgM and IgG3 (the IgG isotype that
does not crossreact to IL-21R-Fc) production (Figure 4F),
whereas blocking IL-4 resulted in a substantial inhibition of IgE
production (Figure 4G). The help of CXCR5+ Th17 cells to naive
B cells was largely dependent on IL-21, as shown by the fact
that blocking IL-21 strongly inhibited the production of IgM,
IgG3, and IgA (Figure 4F).
Thus, the capacity to induce naive B cells to differentiate into
Ig-producing cells was different among blood CD4+ T cell
populations.
CXCR5+ Th Cell Subsets Are Altered in Juvenile
Dermatomyositis
The identification of functionally distinct Th cell subsets within
blood CXCR5+ compartment led us consider that their analysis
might reveal dysregulation of Tfh cell responses in autoimmune
diseases. Juvenile dermatomyositis (JDM) is a chronic, multi-
system autoimmune disease involving muscle, skin, gastrointes-
tinal tract, and other organs. JDM patients with active disease
typically show proximal muscle weakness and skin rash (Feld-
man et al., 2008; Suber et al., 2008). Studies on JDM have
revealed several mediators common to systemic lupus erythe-
matosus, including type I IFN (Walsh et al., 2007). Autoantibodies
can be found in JDM patients’ serum, though relatively little is
known regarding their specificities (Suber et al., 2008). The path-
ogenesis of JDM remains largely unknown.
We analyzed the blood CXCR5+ T cell subsets in samples
from JDM patients (total 52 samples from 45 patients) and
age-matched healthy pediatric controls (43 donors) (summa-(G) IL-10 secretion in supernatants of blood Th cell subsets cultured with naive B c
**p < 0.01.
(H) Ig concentrations at day 12 in the coculture of CXCR5+CD4+ T cells and naive
data from three independent experiments.
(I) CFSE-labeled blood Th cell subsets were cultured with autologous monocytes
day 5. Representative data from two independent experiments.
(J) IL-2 and IFN-g secretion in supernatants at day 2. Data from five independen
(K) PBMCs were stimulated with none, flu vaccine, inactivated flu virus, or SEB f
expression of CD154 in CXCR5+ or CXCR5CD4+ T cells was analyzed. Represerized in Table 1). Blood samples were also obtained from age-
matched pediatric patients with psoriatic arthritis (PSOA, 31
patients), a systemic inflammatory disease mediated by inflam-
matory T cells (Lewkowicz and Gottlieb, 2004). Thirty-five
JDM patients were under standard treatment including cortico-
steroids, methotrexate, Etanercept (TNF antagonist), and/or
high-dose immunoglobulin (Table S1). Twenty-six samples
were obtained from symptomatic JDM patients who displayed
skin rash and/or muscular weakness (measured by the child-
hood myositis assessment scale [CMAS]) at the time of
sampling. These patients included four untreated active patients
(Table S1).
The frequency of CXCR5+ cells within CD4+ T cells was not
substantially different among the three groups (Figure 5A).
However, the frequency of Th1 cells within the CXCR5+CD4+
T cell compartment was significantly lower in JDM patients
when compared to PSOA patients and healthy controls (Fig-
ure 5B; JDM 23.5% ± 0.8%, PSOA 32.8% ± 1.3%, and control
32.4% ± 1.0%; mean ± SEM; both p < 0.0001, one-way
ANOVA test). In contrast, the frequencies of Th2 and Th17 cells
within CXCR5+CD4+ T cells were significantly higher in JDM
patients compared to PSOA patients and healthy controls
(Th2: JDM 29.4% ± 1.0%, PSOA 24.4% ± 1.0%, and control
23.7% ± 0.8%; both p < 0.0001; Th17: JDM 35.8% ± 1.0%,
PSOA 27.9% ± 1.0%, and control 28.1% ± 1.0%; both p <
0.0001). The skewing of CXCR5+ Th cell subsets resulted in
a significant increase in B helpers over non-B helpers in JDM,
as determined by the ratio of Th2+Th17 (B helpers) over Th1
(non B helpers) cells (Figure 5C; JDM 3.1 ± 0.2, PSOA 1.7 ±
0.1, and control 1.7 ± 0.1; mean ± SEM; both p < 0.0001). The
Th cell subsets within the CXCR5 compartment were also
skewed toward Th2 and Th17 cells in JDM patients (Figure S4A).
Of note, in the PSOA group, patients receiving methotrexate
or Etanercept showed comparable frequencies of the CXCR5+
Th cell subsets, indicating that these treatments did not alter
the composition of CXCR5+ Th cell subsets (Figure S4B).
Thus, blood CXCR5+ Th cell subsets were skewed toward Th2
and Th17 cells in JDM patients.
Tfh Cell Subset Skewing Is Associated with Disease
Activity
To determine whether the skewing in Th cell subsets is associ-
ated with disease activity in JDM, patients were subgrouped
according to the severity of clinical manifestations. Active
patients with skin rash and muscular weakness showed a lower
frequency of Th1 cells within CXCR5+ cells than did asymptom-
atic patients (Figure 5D). Accordingly, patients with skin rash
and muscular weakness displayed a higher ratio of
Th2+Th17/Th1 cells in CXCR5+ cells (Figure 5D). The skewingells. Data from four independent experiments. One-way ANOVA test. *p < 0.05,
B cells with indicated amounts of anti-IL-10. n = 3, mean ± SD. Representative
incubated with inactivated flu virus or CMV. Cell proliferation was analyzed at
t experiments. Paired t test. ***p < 0.001, *p < 0.05.
or 6 hr in the presence of Brefeldin A and monensin, and the intracytoplasmic
ntative data from four independent experiments.
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Figure 3. Blood CXCR5+CD4+ T Cells Are Composed of Th1, Th2, and Th17 Cells
(A) CXCR3 and CCR6 expression on blood CXCR5 or CXCR5+CD4+ T cell population. Gated to CD3+CD4+CD45RA cells.
(B) Frequency of populations within blood CXCR5 and CXCR5+CD4+ T cells of ten healthy adults.
(C) The seven blood Th cell populations were cocultured with naive B cells and the secreted IL-21 was measured at 48 hr. n = 3, mean ± SD. Representative data
from four independent experiments.
(D) Other cytokine secretion in the cocultures of the seven blood Th cell populations and naive B cells. n = 3, mean ± SD. Representative data from four
independent experiments.
(E) Expression of each transcriptional factor in the seven blood Th cell populations was assessed by RT-PCR. Representative data from two independent
experiments.
(F) The seven Th cell populations were sorted from PBMCs of three donors, and expression of BCL6 and PRDM1 mRNA was analyzed by real-time RT-PCR.
Normalized to ACTB mRNA expression in each Th cell subset.
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CXCR5+ Th Cell Subsets and Their Alteration in JDMof Th cell subsets is not due to the treatment, as shown by the
fact that neither the frequency of Th1 cells nor the ratio of
Th2+Th17/Th1 cells in CXCR5+ cells were different among active
patients receiving intravenous corticosteroids, high-dose intra-
venous immunoglobulins, or no treatment (Figure 5E). Further-114 Immunity 34, 108–121, January 28, 2011 ª2011 Elsevier Inc.more, patients with skin rash and muscular weakness displayed
a significant increase in the absolute number of CXCR5+
Th2 and Th17 cells in blood, when compared to healthy
controls (Figure 5F; Th2: active JDM [n = 25] 2.0 ± 0.2 versus
healthy [n = 17] 1.3 ± 0.1 3 106 cells/L; mean ± SEM; p = 0.001,
A B C
D
E F G
Figure 4. CXCR5+ Th2 and Th17 Cells Effi-
ciently Help Naive B Cells
(A) Ig secretion by naive B cells cocultured with
the seven blood Th cell populations for 12 days.
n = 3–4, mean ± SD. Representative data from
three independent experiments.
(B) Ig secretion from naive B cells cocultured with
blood CXCR5+ Th cell subsets. Data of three inde-
pendent experiments. One-way ANOVA test.
*p < 0.05, **p < 0.01.
(C) Number of viable CD4+ T cells at day 8. n = 3–4,
mean ± SD. Representative data from two inde-
pendent experiments.
(D) Number of viable B cells and plasmablasts at
day 8. n = 3–4, mean ± SD. Representative data
from two independent experiments.
(E) IgA1 and IgA2 production. Data from three
independent experiments. Student’s t test. *p <
0.05.
(F) Addition of IL-21R-Fc chimera protein to the
cocultures of naive B cells and CXCR5+ Th2 or
Th17 cells. n = 3, mean ± SD. Student’s t test.
*p < 0.05, **p < 0.01, ***p < 0.001. Representative
data from three independent experiments.
(G) Addition of IL-4 blocking antibody to the
culture of CXCR5+ Th2 cells and naive B cells.
n = 3, mean ± SD. Student’s t test. **p < 0.01.
Representative data from two independent exper-
iments.
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Table 1. Summary of Patients and Donors in the Study
JDM (52 Samples) PSOA (31 Samples) Health (43 Samples)
Symptomatic Asymptomatic p Value (t Test)
Mean Range Mean Range Mean Range Mean Range
JDM
Symptomatic versus
Asymptomatic
JDM
Symptomatic
versus PSOA
JDM
Asymptomatic
versus PSOA
JDM
Symptomatic
versus Health
JDM
Asymptomatic
versus Health
Age 10.1 ± 4.7 3–18 10.8 ± 4.0 5–18 8.7 ± 4.0 3–17 10.6 ± 4.5 2–18 0.54 0.23 0.21 0.82 0.64
WBC 7.8 ± 3.5 3.7–15.2 7.0 ± 2.1 4.5–11 6.6 ± 1.9 3.6–13.1 0.36 0.09 0.40
Hgb 12.7 ± 0.9 10.9–14.4 13.5 ± 1.0 11.7–15.9 12.8 ± 1.1 9.9–14.8 0.007 0.550 0.03
Plat 300 ± 66 173–424 306 ± 84 151–422 326 ± 88 194–501 0.74 0.21 0.43
Neu 4.6 ± 2.7 1.44–10.39 3.7 ± 1.8 1.71–9.72 3.4 ± 1.5 0.9–8.7 0.19 0.03 0.44
Lym 2.0 ± 0.8 0.4–3.47 2.4 ± 1.0 0.85–5.06 2.4 ± 0.7 1.10–4.12 0.08 0.11 0.58
Mon 0.9 ± 0.5 0.22–2.31 0.6 ± 0.2 0.25–1.3 0.6 ± 0.2 0.17–0.91 0.03 0.002 0.34
ESR 17.0 ± 11.7 3–53 10.7 ± 10.1 1–41 8.8 ± 6.0 2–25 0.06 0.001 0.38
CPK 1381 ± 3207 25–11332 87 ± 47 19–207 91 ± 30 56–162 0.07 0.12 0.80
ALD 6.9 ± 5.8 2.6– >25 4.5 ± 1.7 2.5–8.5 4.8 ± 1.3 2.3–8.0 0.07 0.17 0.51
LDH 327 ± 249 126–1236 199 ± 45 127–285 218 ± 46 123–319 0.02 0.02 0.15
AST 68 ± 100 16–389 22.6 ± 7.2 12–35 26 ± 9 11–46 0.04 0.02 0.13
ALT 43 ± 59 7–267 15.2 ± 6.1 9–35 19 ± 10 7–49 0.03 0.03 0.20
CMAS 40.0 ± 13.6 0–52 51.6 ± 1.0 48–52 N/A 0.0002
Gender of samples was as follows: JDM symptomatic, M10/F17; JDM asymptomatic, M4/F21; PSOA, M6/F25; healthy, M29/F14. Statistically significant p values (p < 0.05) are shown in bold.
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Figure 5. Blood CXCR5+ Th Cell Subsets Are Altered in JDM
(A) Percentage of CXCR5+ cells within CD4+ T cells in samples from JDM patients (n = 52), PSOA patients (n = 31), and age-matched healthy controls (n = 43).
(B) Percentage of each Th cell subset within blood CXCR5+CD4+ T cells. One-way ANOVA test, **p < 0.01, ***p < 0.001.
(C) Ratio of CXCR5+ (Th2+Th17)/Th1 cells. One-way ANOVA test.
(D) Frequency of CXCR5+ Th1 cells and ratio of (Th2+Th17)/Th1 cells in JDM patients with different disease activities. One-way ANOVA test.
(E) Frequency of CXCR5+ Th1 cells and ratio of (Th2+Th17)/Th1 cells in active JDM patients receiving none, intravenous corticosteroids, or high-dose Ig
treatments.
(F) The absolute cell numbers in blood were calculated based on the complete blood cell count, lymphocyte frequency within white blood cells, and the frequency
of CXCR5+ Th cell subsets within the lymphocyte population. Student’s t test.
Immunity
CXCR5+ Th Cell Subsets and Their Alteration in JDMt test; Th17: active JDM 2.4 ± 0.2 versus healthy 1.7 ± 0.2 3
106 cells/L; p = 0.03). Lastly, JDM patients displayed higher
serum IgG concentrations than did PSOA and control groups
(Figure S4C).
Analysis of blood B cell subsets revealed that JDM patients,
particularly in those displaying both skin rash and muscular
weakness, displayed higher numbers of circulating plasmablasts
(CD19+CD20CD27+CD38hi cells) (Arce et al., 2001) than
PSOA patients and controls (Figures 6A and 6B). The number
of circulating plasmablasts was similar among symptomatic
patients regardless of treatment modality (Figure 6C). The fre-quency of plasmablasts within CD19+ B cells correlated posi-
tively with the extent of skewing of CXCR5+ Th cell subsets
toward Th2+Th17 cells (Figure 6D, top left) and negatively
with the frequency of CXCR5+ Th1 cells (Figure 6D, top right).
The correlation between the frequency of plasmablasts and
the skewing of CXCR5+ Th cell subsets was limited to symptom-
atic patients (rash and/or muscular weakness) (Figure 6D,
middle and bottom). In contrast, the frequency of plasmablasts
did not correlate with the frequency of either total CXCR5+
CD4+ T cells (Figure 6E, left) or ICOS+CXCR5+CD4+ T cells
(Figure 6E, right). Furthermore, neither the skewing of Th cellImmunity 34, 108–121, January 28, 2011 ª2011 Elsevier Inc. 117
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Figure 6. Skewing in Blood CXCR5+ Th Cell Subsets Correlates with B Cell Alteration
(A) The absolute number of plasmablasts in blood of JDM patients, PSOA patients, and healthy controls (left), and in JDM patients with different disease activities
(right). One-way ANOVA test.
(B) Percentage of plasmablast within total CD19+ B cells.
(C) The absolute number of plasmablasts in blood of active JDM patients receiving none, intravenous corticosteroids, or high-dose Ig treatments.
(D) Correlation between the percentage of plasmablasts within CD19+ B cells and the ratio of CXCR5+ (Th2+Th17)/Th1 cells (left) or the frequency of CXCR5+ Th1
cells (right) in JDM. Pearson correlation coefficient and two-tailed p value are shown.
(E) Correlation between the percentage of plasmablasts within CD19+ B cells and the frequency of total CXCR5+CD4+ T cells (left) or of ICOS+ CXCR5+CD4+
T cells (right).
(F) Correlation between the percentage of plasmablasts and the ratio of CXCR5 (Th2+Th17)/Th1 (left) or the frequency of CXCR5 Th1 cells (right) in active JDM
patients.
Immunity
CXCR5+ Th Cell Subsets and Their Alteration in JDMsubsets within CXCR5CD4+ T cells nor the frequency of
CXCR5 Th1 cells correlated with the frequency of plasmablasts
(Figure 6E).
Collectively, in JDM patients, the alteration of blood CXCR5+
Th cell subsets correlated with disease activity and with an
increase in circulating plasmablasts.118 Immunity 34, 108–121, January 28, 2011 ª2011 Elsevier Inc.DISCUSSION
Our study shows that blood CXCR5+CD4+ T cells share func-
tional properties with Tfh cells from secondary lymphoid organs.
In concordance with Tfh cells, blood CXCR5+CD4+ T cells
induced naive and memory B cells to become Ig-producing cells
Immunity
CXCR5+ Th Cell Subsets and Their Alteration in JDMvia IL-21, IL-10, and ICOS and secreted CXCL13. At variance
with Tfh cells, blood CXCR5+CD4+ T cells barely expressed
CD69 and ICOS, and PD-1 only at low intensity (Kim et al.,
2001; Ma et al., 2009; Simpson et al., 2010), suggesting that
they are in a resting state. Consistently, blood CXCR5+CD4+
T cells required cell activation to provide help to B cells through
cognate interaction. Whereas CXCR5 can be expressed by any
activated CD4+ T cells (Schaerli et al., 2001), dissociation in
the expression of CXCR5 and activation molecules such as
CD69 and ICOS suggests that blood CXCR5+CD4+ T cells do
not represent recently activated cells. In contrast to Tfh cells,
blood CXCR5+CD4+ T cells express CCR7 and CD62L, suggest-
ing their capacity to migrate into secondary lymphoid organs.
Thus, it is plausible that upon microbial invasion, CXCR5+CD4+
T cells draining into lymphoid organs interact with B cells pre-
senting microbial antigens and induce their differentiation into
Ig-producing cells or germinal center B cells through secretion
of IL-21 (Linterman et al., 2010; MacLennan et al., 2003; Zotos
et al., 2010).
Our study shows that human blood CXCR5+CD4+ T cells are
composed of three subsets: Th1, Th2, and Th17 cells. CXCR5+
Th2 and CXCR5+ Th17 cells induced naive B cells to secrete
Igs through IL-21 but differentially modulated isotype switch.
Whereas CXCR5+ Th2 cells promoted IgG and IgE secretion,
CXCR5+ Th17 cells promoted IgG and, in particular, IgA secre-
tion. These findings suggest that Tfh cells associated with
different Th cell subsets differentially shape the quality of human
humoral immunity. In support of this hypothesis, only a fraction of
tonsillar Tfh cells produces IL-4 together with IL-21 (Lane et al.,
2005; Ma et al., 2009; Yu et al., 2009). Th2-type Tfh cells were
also demonstrated in mice (King and Mohrs, 2009; Reinhardt
et al., 2009; Zaretsky et al., 2009). The difference between
mouse and human Tfh cellsmight lie on the role of Th1-type cells.
Mouse studies identified IFN-g-secreting Th1-type Tfh cells in
GCs, which promote the class-switching of GC B cells toward
IgG2a (Reinhardt et al., 2009). This is in contrast to human
CXCR5+ Th1 cells, which were incapable of helping B cells.
Indeed, IFN-g does not have any impact on isotype switching
of human B cells (Banchereau et al., 1994).
Among blood CXCR5CD4+ T cells, only CXCR5 Th2 cells
induced naive B cells to become plasmablasts producing IgM
and IgE. CXCR5 Th17 cells were unable to induce naive B cells
to secrete Igs. Neither CXCR5 Th2 nor CXCR5 Th17 cells
secreted IL-21 upon interaction with naive B cells. The molecular
mechanisms whereby two different types of effectors, i.e., B
helpers and non-B helpers, emerge from Th2 and Th17 cell
subsets remain to be established. Multiple factors are probably
involved in this process, including DC subsets that prime naive
CD4+ T cells (Klechevsky et al., 2008), cytokines secreted by
DCs (Deenick et al., 2010; Dienz et al., 2009; Schmitt et al.,
2009) or other cell types including neighboring Th cells (Nurieva
et al., 2008; Vogelzang et al., 2008), T cell receptor affinity against
peptide-MHCcomplex (Fazilleau et al., 2009), and the interaction
with B cells (Nurieva et al., 2008; Zaretsky et al., 2009).
Whether human blood CXCR5+CD4+ T cells originate from
cells that migrated out of GCs or Tfh cell-committed extrafollic-
ular helper cells (MacLennan et al., 2003; Poholek et al., 2010)
will be challenging to address in humans. Notably, consistent
with a previous report (Simpson et al., 2010), the expression ofBCL6 transcript was similar between blood CXCR5+ and
CXCR5 Th cell subsets. However, the expression of PRDM1
transcript was lower in all the Th cell subsets in CXCR5+ cells
than their counterparts in CXCR5 cells. Given the reciprocal
regulation between Bcl-6 and Blimp-1 in the generation of Tfh
cells (Johnston et al., 2009), maintaining the expression of
Blimp-1 at low amounts might be a feature of memory Tfh cells.
Alternatively, in concordance with B cells (Kuo et al., 2007),
downregulation of Bcl-6 might be necessary for germinal center
Tfh cells to become memory cells.
Our study on JDMsuggests that the alteration in the balance of
Tfh cell subsets can be associated with autoimmunity in humans.
Higher numbers of circulating plasmablasts in active JDM
patients and a high relevance of antinuclear antibodies prompted
us to analyze blood CXCR5+ subsets in these patients. Overrep-
resentation of Th2 and Th17 cells and underrepresentation of Th1
cells in both CXCR5+ and CXCR5 cells suggest that the overall
regulation of Th cell differentiation is altered in JDM patients. The
alteration in CXCR5+ Th cell subsets, however, correlated better
with the frequency of circulating plasmablasts than that in
CXCR5 Th cell subsets and thus represents a better biomarker
to assess the dysregulation of B cell responses in this disease.
Our findings support the idea that humoral responses are
differentially regulated by different subsets of Tfh cells in
humans. This might have important implications for the design
of novel vaccines. For example, induction of Th2- and Th17-,
but not Th1-type, Tfh cells would be desired for efficient antibody
responses to vaccination. In particular, the discovery of the
Th17-type CXCR5+CD4+ T cell subset as a potent IgA inducer
could guide the design of vaccines for protective mucosal immu-
nity. Further characterization of blood CXCR5+CD4+ T cells as
well as secondary lymphoid organ Tfh cells will provide insights
into the pathogenesis and perhaps identify novel therapeutic
targets for human autoimmune diseases.
EXPERIMENTAL PROCEDURES
Blood Samples
PBMCs purified from apheresis blood samples obtained from adult healthy
volunteers were used in the experiments. Fresh blood samples were also
collected from JDM (n = 52), PSOA patients (n = 31), and age-matched pedi-
atric controls (n = 43). Detailed clinical characteristics, clinical lab data, and
treatment at the time of analysis are shown in Table S1. The study was
approved by the Institutional Review Boards (IRBs) of UT Southwestern
Medical Center, Texas Scottish Rite Hospital, and Baylor Health Care System.
Informed consent was obtained from parents or legal guardians.
Cell Isolation
CD4+ T cells enriched by negative selection were stained with the anti-CD4
FITC (RPA-T4), anti-CXCR5 PE (51505.111), anti-CD45RA TC (MEM-56),
anti-CD14 APC (61D3), and anti-CD123 APC (AC145). Then, naive, CXCR5
memory, and CXCR5+ memory CD4+ T cells were sorted from APC-negative
cell fractions. For CXCR5+ Th cell subset sorting, enriched CD4+CD45RA
T cells were stained with anti-CCR6 biotin (11A9) + SA-TC, anti-CXCR3 FITC
(49801), anti-CXCR5 PE, and anti-CD4 APC. Positively selected CD19+ B cells
were stained with anti-IgD FITC (IA6-2), anti-CD27 PE (L128), and anti-CD3
APC. Naive and memory B cells were sorted as IgD+CD27CD3 and CD27+
CD3CD19+ cells, respectively.
CD4+ T Cell and B Cell Coculture
Naive B cells were coculturedwith sorted CD4+ T cells (23 104 cells each/well;
5 3 104 cells each/well for cytokine measurement) in the presence ofImmunity 34, 108–121, January 28, 2011 ª2011 Elsevier Inc. 119
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CXCR5+ Th Cell Subsets and Their Alteration in JDMendotoxin-reduced SEB (1 mg/ml) in RPMI 1640 complete medium supple-
mented with 10% heat-inactivated FBS. Cytokine concentrations were
measured in the culture supernatants at day 2 by Luminex, and the Ig concen-
trations were measured at day 12 by ELISA.
Real-Time RT-PCR
Total RNAwas extracted from blood Th cell subpopulations or cultured B cells.
Real-time PCR was set up with Roche Probes Master reagents and Universal
Probe Library hydrolysis probes. PCR reaction was performed on the
LightCycler 480 (Roche Applied Science) according to these conditions:
step 1 (denaturation) at 95C for 5 min, step 2 (amplification) at 60C for
30 min, and step 3 (cooling) at 40C for 30 s. The expression of each gene
was normalized to housekeeping gene ACTB.
Phenotypical Analysis of Blood Samples
Whole blood cells were stained with these mAbs: CXCR5-Alexa488 (RF8B2),
CCR6-PE (11A9), CD45RA-ECD (2H4LDH11LDB9), CXCR3-PECy5 (1C6),
CD3-AF700 (UCHT1), CD4-Pacific Blue (RPA-T4), CD45-Pacific Orange
(HI30), CD19-ECD (J3.119), CD20-PECy5 (2H7), CD38-PECy7 (HB7), and
CD27-APCH7 (O323). The stained cells were analyzed with BD LSRII.
Statistics
The significance of the difference between groups was analyzed with one-way
ANOVA test with Bonferroni correction. The significance of the difference
between two groups was evaluated by F-test followed by the two-tailed
Student’s or paired t test. A Wilcoxon signed-ranks test was applied when
data did not show Gaussian distribution. Pearson correlation coefficient and
two-tailed p value were determined in the analysis of correlations.
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